生物素拯救了诱导的帕金森病表型和神经毒性
bioRxiv : the preprint server for biology
|December 4, 2023
概括
(Mn) 暴露会通过破坏生物素 (维生素B7) 代谢引起帕金森氏症的症状. 补充生物素在和人类细胞中逆转了这些效应,这表明神经退行性疾病的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 由于症状重叠, (Mn) 暴露与帕金森病 (PD) 有关.
- 连接Mn毒性和PD的分子机制在很大程度上是未知的.
- 目前缺乏有效的基于机制的PD治疗方法.
研究的目的:
- 为了研究毒性与帕金森病之间的分子联系.
- 为了确定关键的代谢途径参与诱导的神经毒性.
- 探索对和PD的潜在治疗干预措施.
主要方法:
- 开发了一个成年 *Drosophila* 毒性模型.
- 进行全球代谢分析以确定受影响的途径.
- 使用生物素缺乏和野生类型的以及人类iPSC衍生的多巴胺基神经元进行了救援实验.
主要成果:
- 的毒性破坏了生物素 (维生素B7) 的新陈代谢,导致生物素水平的系统性增加.
- 生物素枯竭加剧了Mn诱导的神经毒性和帕金森症表型.
- 生物素补充剂显著改善了Mn诱导的行为缺陷,神经元损失和和人类细胞中的线粒体功能障碍.
- 患有PD的患者表现出循环生物素载体的升高,这表明它在疾病发病过程中起作用.
结论:
- 生物素途径是毒性和帕金森病样病理学的关键,融合的调解者.
- 生物代谢中的补偿性改变驱动Mn诱导的神经退行.
- 准生物素通路为和帕金森病提供了一种新的治疗策略.
更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.6K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
相关概念视频
01:24Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
01:15Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557